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1. Introduction
  Infections caused by gram negative bacteria are difficult 
to treat as the majority of isolates exhibit varying degrees 
of beta-lactamase mediated resistance to most of the beta-
lactam antibiotics. The genes coding for 毬- lactamase 
enzymes mutate continuously in response to the heavy 
pressure of antibiotic use lead to development of newer
毬- lactamases with broad spectrum of activity[1]. Amongst 
毬-lactamases, the carbapenemases especially metallo-毬
-lactamases (MBL) are a major cause of concern because of 
their ability to hydrolyze most beta-lactams including the 
carbapenems, drugs considered reserve for the treatment of 
gram negative multidrug resistant strains[2]. The worldwide 
spread of MBLs represents a great fear nowadays not only 
due to their ability to confer a high level of resistance but 
also because their genes carried highly mobile elements that 
facilitates their spread among different bacterial species and 
genera[3]. Their ability to inactivate many broad spectrum 
antimicrobial agents, and increase in their prevalence 
would drastically compromise the ability to effectively 
treat hospital or community acquired infections caused 
predominantly by gram negative bacilli[4]. Moreover, MBLs 
are not susceptible to therapeutic 毬- lactamase inhibitors 
and no new inhibitor of these enzymes is yet in the pipeline, 
hence their continued spread would be a clinical disaster[5]. 
This situation prompts an early and accurate detection of 
MBL producing organisms of crucial importance like non-
fermenting pathogens[4]. The present study was undertaken 
to evaluate the accuracy of various phenotypic tests for 
detection of MBL-producing isolates among Pseudomonas 
aeruginosa (P. aeruginosa) and Acinetobacter spp.  
2. Materials and methods 
  A prospective study was conducted to 109 consecutive 
non-duplicate isolates of P. aeruginosa and 85 isolates 
of Acinetobacter spp., which were obtained from patients 
admitted in various wards and ICUs at a tertiary care 
hospital over a period of 7 months (July 2009-January 2010). 
These organisms were isolated from various specimens 
included sputum, bronchoalveolar lavage, tracheal aspirate, 
pus, pleural fluid, ascitic fluid and were identified by the 
standard laboratory techniques[6,7].  
  Antimicrobial sensitivity testing was performed on Mueller 
Hinton agar (MHA) by Kirby-Bauer disk diffusion method 
according to the CLSI recommendations[8]. The following 
antibiotics were tested: imipenem (10 毺g), cefoperazone
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(75 毺g),  cefoperazone/sulbactam (75 毺g/30毺g), 
ciprofloxacin (5 毺g), piperacillin (100 毺g), piperacillin/
tazobactam (100 毺g/10毺g), amikacin (30 毺g), and 
polymixin B (300 units) (BD Diagnostics Pvt. Ltd., India).
  Screening for MBL production was performed in all 
imipenem resistant isolates and randomly selected ten 
imipenem sensitive isolates by different phenotypic 
methods.
2.1. Imipenem (IMP)-EDTA combined disc test[9]
  A 0.5 McFarland suspension of the test organism was 
inoculated on a MHA plate as per CLSI guidelines[8]. Two 
10 毺g imipenem disks were placed on the plate. An 
appropriate amount of 10 毺L of 0.5 M EDTA solution was 
added to one of the disc to obtain the desired concentration. 
Plates were incubated at 37 曟 for 18-24 hours. The zone 
of inhibition of the imipenem and imipenem-EDTA disks 
was compared for the detection of MBLs. For P. aeruginosa, 
if the increase in the inhibition zone with the imipenem-
EDTA disk was ≥7 mm than imipenem disk alone it was 
taken as MBL positive. However for Acinetobacter spp. zone 
of inhibition of imipenem-EDTA disk was measured which 
was ≥ 17 mm for MBL positive and ≤ 14  mm were taken as 
MBL negative (Figure 1). 
Figure 1. Imipenem- EDTA combined disc test. 
Increase in the diameter of zone of inhibition around imipenem+ 
EDTA disc in comparison to imipenem disc alone indicate MBL 
positive.
2.2. Double disc synergy tests (DDST)[10]
  An overnight liquid culture of the test isolate was adjusted 
to turbidity 0.5 McFarland standards and inoculated on the 
surface of MHA as recommended by CLSI[10]. An imipenem 
disk (10 毺g) was aligned around blank filter paper disk at 
a distance of 20 mm from centre to centre on MHA plate. 
To the blank disk either 10 µL of 0.5 M EDTA or 3 µL of 
concentrated 2-mercaptopropionic acid (MPA) solution 
was added directly. After overnight incubation 37 曟, an 
enhancement of the zone of inhibition between imipenem 
and the inhibitor disk was indicative of MBL production.
2.3. MBL E-test
  The E-test MBL strip (AB Biodisk, Solna, Sweden) 
containing double sided seven dilution range of imipenem 
(4-256 毺g/mL) and imipenem (1 to 64 µg/mL)in combination 
with a fixed concentration of EDTA. MIC ratio of IP/IPI of 
≥8 or ≥3 log2 dilutions indicated MBL production[11]. 
Appearance of a phantom zone or deformation of the ellipse 
is also taken as positive for MBL regardless of the IP/IPI ratio 
(Figure 2).
Figure 2. MBL E test.
MIC ratio of IP (imipenem)/IPI (imipenem-EDTA) of >8 or >3 log2 
dilutions indicates MBL positive.
3. Results
  A total of 63 (57.8%) strains of P. aeruginosa and 46 (54.1%) 
strains of Acinetobacter spp. were found to be resistant to 
imipenem. 
  Of the 63 imipenem resistant P. aeruginosa tested for 
MBL production, 44 (69.8%)  exhibited a ≥7 mm zone size 
enhancement in imipenem-EDTA combined disk test 
indicated MBL producers. 39 (57.1%) isolates gave positive 
result by DDST using imipenem and  EDTA. 33 (52.3%) were 
found to be positive on DDST using imipenem and MPA. 
MBL E-test was done in 15 isolates (12 of which were both 
combined disk test and DDST test positive and 3 isolates 
were randomly tested from those strains which gave positive 
combined disk test and negative DDST). All the 15 isolates 
were shown to be MBL producers by E-test method. Phantom 
zone between IP/IPI was noted in 3 isolates. 
  Among the 46 imipenem resistant Acinetobacter spp., 19 
(41.3%) were found to be MBL producers by combined disc 
test, 12 (26.0%) gave positive results by EDTA disk synergy 
test and 9 (19.5%) were positive on MPA disk synergy test. 
E-test was performed in 12 isolates (MBL producers by 
combined disk test) and was found to be positive in all these 
isolates. 
  No MBL production was seen in 10 randomly selected 
imipenem sensitive strains screened by various phenotypic 
methods.
  The antimicrobial resistance patterns of the isolates are 
depicted in Table 1. P. aeruginosa showed maximum 
sensitivity (100.0%) to polymyxin B followed by imipenem 
(42.2%), piperacillin-tazobactam (36.7%), cefoperazone-
sulbactam (34.9%) and amikacin (34.9%). All Acinetobacter 
spp. were also found to be sensitive to polymyxin B 
and showed moderate sensitivity to imipenem (45.9%), 
piperacillin-tazobactam(38.8%), cefoperazone-sulbactam 
(36.5%) and ciprofloxacin (25.9%). Poor susceptibility was 
seen with the rest of the drugs as shown in Table 1.
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4. Discussion
  Carbapenems are 毬- lactam antibiotics, considered as the 
most potent agents of treatment of multidrug resistant gram 
negative bacterial infections due to the stability of these 
agents against the majority of 毬- lactamases and their 
high rate of permeation through bacterial outer membranes. 
However, in the last decade there is an alarming increase 
in reports of resistance to these life saving antimicrobials 
and poses a significant clinical challenge[12]. Production 
of MBLs has emerged as the most important mechanism 
of carbapenem resistance among non-fermentative gram 
negative bacterial isolates due to the facilitation of rapid 
spread by the transfer of integrons containing gene cassettes 
for resistance to multiple antibiotics. For many years, these 
MBL producing isolates were restricted to several countries 
but now it has disseminated worldwide[1,13,14].
  The present study reports high level of imipenem resistance 
(57.8% and 54.1%) among P. aeruginosa and Acinetobacter 
spp. respectively. Previous studies from India also showed 
rising trend (14.0%-36.4%) in the carbapenem resistance 
among the non-fermenters[1,15,16]. In P. aeruginosa,
resistance has gone up to even 60% across the world[17,18]. 
Surveillance in Brooklyn, New York revealed that 
approximately 2 of every 3 isolates of Acinetobacter were 
resistant to carbapenem[19]. In another study, 64% of 
resistance to meropenem was reported in Acinetobacter 
spp[20]. High antibiotic pressure due to greater empirical 
or indiscriminate use of antibiotics could have result the 
carbapenem resistance in the hospital setting. We also found 
that 69.8% of the imipenem resistance among P. aeruginosa 
was attributable to production of MBLs which is comparable 
to the another study reporting a similar pattern of resistance 
(61.3%)[12]. In India, MBL producing P. aeruginosa was first 
reported in 2002 and been seen to vary from as low as 7.5% 
to 75%.[17,21,22] The prevalence of MBL positive strains among 
imipenem non susceptible Acinetobacter was lower than in 
P. aeruginosa. Among the imipenem resistant Acinetobacter, 
41.3% were MBL producers which was relatively less 
compared to the other Indian studies[1,21] according to 
which MBL may not play a major role in resistance among 
the Acinetobacter. But our findings clearly show a rising 
trend in the carbapenem resistance due to MBLs among the 
Acinetobacter spp. especially in hospitalized patients. 
  With the global increase in the types of MBLs, early 
detection is crucial. The CLSI does not have performance 
standards documented so far, various screening methods 
have been employed for screening of clinical isolates for 
MBL production. Though MIC detection is gold standard, 
combined disc test and DDST are comparable with the 
former and at the same time are simple, reliable, less 
cumbersome and cheap, as per previous reports[17,23]. In 
this study, we have used four different methods of screening 
of MBL production. With the imipenem–EDTA combined 
disk test, the positive and negative results were more clearly 
discriminated and were found to be more superior to DDST 
and detected highest number of MBL producing isolates in 
both P. aeruginosa and Acinetobacter spp. The reason for the 
difference in the performance of these two tests is exactly 
not clear but interpretation of the combined disk assay 
results is more objective than that of DDST results because 
the DDST depends upon the expertise in discriminating true 
synergism from intersection of inhibition zones. One major 
disadvantage of DDST was the subjective interpretation of 
result in some instances as both the EDTA and MPA discs 
alone frequently produced undesirably large inhibition 
zones. Our findings are supported by other published studies 
which have found the combined disc method to be the more 
sensitive technique for detecting MBLs[17,24,25]. Among the 
DDST, the performance of IMP-EDTA was compared with 
IMP-MPA and the former provided the better results over 
MPA in both of P. aeruginosa and Acinetobacter isolates .
  In present study, the MBL E test is found to be very 
sensitive for detection of MBLs in P. aeruginosa as well as 
in Acinetobacter spp. All isolates positive by combined disc 
test were also found to be positive with E test and other few 
which were positive by combined disc test and negative by 
DDST were also detected as MBL producers by E test. The 
MBL E test strip has the ability to detect both chromosomally 
and plasmid mediated MBLs, is simple to perform with ease 
of application as well as interpretation. However, it has a 
disadvantage of being unable to provide conclusive results 
in strains with low MICs to be detected by the test strip and 
of utility only in differentiating MBL producers in imipenem 
resistant strains. Moreover, given the cost constraints of 
E test, other screening methods like combined disc test 
and DDST have been reported to be simple, inexpensive 
phenotypic resources for the detection of MBL that could 
be easily incorporated into the routine testing of any 
microbiology laboratory[11,17].
  The unique problem with MBLs is their broad spectrum 
resistance profile. Multidrug resistance was observed with 
a higher frequency among the MBL producers in this study. 
Apart from imipenem, MBLs were found to be resistant 
to other important groups of antibiotics tested including 
cephalosporins, aminoglycosides and fluoroquinolones. 
All the isolates were seen to be susceptible to polymyxin 
B. Since these organisms carry other drug-resistant 
Table 1 
Antimicrobial resistance pattern of various isolates.
Antimicrobial agent P. aeruginosa( n=109) Acinetobacter spp (n=85)
Ciprofloxacin  79.8% 74.1%
Amikacin  65.1% 81.2%
Piperacillin  90.8% 95.3%
Cefoperazone  96.3% 95.3%
Piperacillin –tazobactam  63.3%  61.1%
Cefoperazone-sulbactam 65.1% 63.5%
Imipenem 57.8% 54.1%
Polymyxin B   0.0%   0.0%
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genes, limited treatment options are available and the 
only therapeutic alternative remains the potentially toxic 
polymyxin B and colistin[6]. So,early identification of the 
infections due to these organisms is necessary as the 
appropriate treatment might reduce the spread of these 
resistant strains as well as reduce the mortality among 
hospitalized patients.
  The limitations in the present study are relatively small 
sample size and were restricted mainly to the detection of 
metallo- beta- lactamases among non fermentative bacteria. 
However use of additional features including large study 
sample and clinical usefulness of detection of MBLs would 
have enhanced the value of study and may have provided 
greater insight into the possible link.
  To conclude, MBL production is an important mechanism 
of carbapenem resistance among non-fermentative gram 
negative bacilli. Detection of MBLs by simple, inexpensive 
and reproducible methods should be routinely performed for 
all imipenem-resistant isolates. We found imipenem-EDTA 
combined disc test and MBL E test to be equally effective 
for MBL detection, however given the cost factor, combined 
disk test could be used as convenient screening method 
in the clinical microbiology laboratories. But at the same 
time, standardization of phenotypic methods is of crucial 
importance. Moreover, a strict antibiotic policy, timely 
implementation of infection control practices and antibiotic 
resistance surveillance programs should be carried out from 
time to time.  
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